| ThrIVe-B (n = 22) | Treatment as usual (n = 21) | Total (N = 43) |
---|---|---|---|
Gender; n (%) | |||
 Female | 14 (64) | 9 (43) | 23 (53) |
 Male | 8 (36) | 12 (57) | 20 (47) |
Age in years | Â | Â | Â |
 Mean (SD) | 43.6 (13.0) | 49.3 (14.5) | 46.4 (13.9) |
 Median [min, max] | 43 [20, 68] | 51 [24, 75] | 44 [20, 75] |
Ethnic group; n (%) | |||
 White | 22 (100) | 20 (95) | 42 (98) |
 Asian | 0 (0) | 1 (5) | 1 (2) |
Prescribed medication for | |||
 Bipolar disorder; n (%) | 19 (86) | 19 (90) | 38 (88) |
 Mood stabiliser | 14 (63) | 12 (57) | 26 (61) |
 Antipsychotic | 10 (46) | 14 (67) | 24 (56) |
 Antidepressant | 7 (32) | 8 (38) | 15 (35) |
Site; n (%) | |||
 Devon | 17 (77) | 17 (81) | 34 (79) |
 Cumbria | 5 (23) | 4 (19) | 9 (21) |
In ongoing secondary care; n (%) | |||
 Yes | 2 (9) | 4 (19) | 6 (14) |
 No | 20 (91) | 17 (81) | 37 (86) |
Age of depression onseta; mean (SD), n; median [min, max] | 19.4 (12.6), 19 16 [6, 58] | 18.7 (8.4), 20 18 [6, 44] | 19.1 (10.5), 39 18 [6, 58] |
Age of mania onset; mean (SD), n; median [min, max] | 21.1 (7.9), 15 20 [10, 35] | 16.5 (5.7), 17 18 [6, 25] | 18.7 (7.1), 32 18 [6, 35] |
Bipolar I disorder; n (%) | 19 (86) | 18 (86) | 37 (86) |
Bipolar II disorder; n (%) | 3 (14) | 3 (14) | 6 (14) |